FLUIMUCIL 600 600mg Šumeća tableta الجبل الأسود - الكرواتية - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

fluimucil 600 600mg šumeća tableta

"farmont m.p." d.o.o. za proizvodnju, promet i usluge, export-import danilovgrad - acetilcistein - Šumeća tableta - 600mg

Ogluo الاتحاد الأوروبي - الكرواتية - EMA (European Medicines Agency)

ogluo

tetris pharma b.v - glukagon - Šećerna bolest - hormoni pankreasa hormoni glycogenolytic - ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.

TachoSil الاتحاد الأوروبي - الكرواتية - EMA (European Medicines Agency)

tachosil

corza medical gmbh - ljudskog fibrinogena, ljudskog trombina - hemostaza, kirurški - antihemorrhagics - tachosil is indicated in adults and children from 1 month of age for supportive treatment in surgery for improvement of haemostasis, to promote tissue sealing and for suture support in vascular surgery where standard techniques are insufficient. tachosil is indicated in adults for supportive sealing of the dura mater to prevent postoperative cerebrospinal leakage following neurological surgery (see section 5.

GlucaGen HypoKit 1 mg prašak i otapalo za otopinu za injekciju كرواتيا - الكرواتية - HALMED (Agencija za lijekove i medicinske proizvode)

glucagen hypokit 1 mg prašak i otapalo za otopinu za injekciju

novo nordisk a/s, novo alle, bagsvaerd, danska - glukagonklorid - prašak i otapalo za otopinu za injekciju - 1 mg - urbroj: jedna bočica sadrži 1 mg glukagona u obliku klorida, što odgovara 1 mg (1 iu) glukagona/ml nakon rekonstitucije

Topotecan Actavis الاتحاد الأوروبي - الكرواتية - EMA (European Medicines Agency)

topotecan actavis

actavis group ptc ehf - topotekan - uterine cervical neoplasms; small cell lung carcinoma - antineoplastična sredstva - monoterapija topotekan je indicirana za liječenje bolesnika s relapsirajućim karcinomom pluća malih stanica [sclc] za koje ponovno liječenje s režimom prvog reda nije prikladno. Топотекана u kombinaciji s цисплатином je indiciran u bolesnika s карциномой relaps grlića maternice nakon radioterapije i za pacijente sa fazi bolesti instituta svjetske banke . pacijenti s preliminarnim utjecajem cisplatinu, zahtijevaju stalnu besplatno liječenje interval, da se opravda liječenje kombinacije.

Thiotepa Riemser الاتحاد الأوروبي - الكرواتية - EMA (European Medicines Agency)

thiotepa riemser

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastična sredstva - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.